QPS Medical and Regulatory Affairs Departments are focused on partnering with pharmaceutical, biotech and medical device companies to ensure the successful development of their clinical drug development programs.

Our expertise encompasses discovery, preclinical, clinical, and commercial regulatory services to bring new technologies to patients faster.

We are committed to ensuring compliance and fostering innovation in the healthcare industry.

Partnering with QPS for a well-conceived and well-executed IND package development and submission will provide you with the most agile, flexible and timely pathway to filing an IND.



Before we begin executing your IND submission program, our preclinical and clinical teams will work together to provide a comprehensive strategic review and of the design and execution of your ADME and pharmacology-toxicology studies.

During execution of your IND-enabling program you will benefit from QPS’s operational strengths, strong scientific/regulatory IND support, and drug development experience.